welcome
TechCrunch

TechCrunch

Health

Health

Ready-made stem cell therapies for pets could be coming | TechCrunch

TechCrunch
Summary
Nutrition label

84% Informative

San Diego startup Gallant announced $18 million in funding to bring the first FDA -approved ready-to-use stem cell therapy to veterinary medicine.

Gallant 's first target is a painful mouth condition in cats called Feline Chronic Gingivostomatitis ( FCGS ), which Gallant says could receive FDA approval by early 2026 .

VR Score

86

Informative language

86

Neutral language

52

Article tone

formal

Language

English

Language complexity

54

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

Affiliate links

no affiliate links